Tenet reports second quarter 2022 results; reaffirms 2022 adjusted ebitda outlook

Dallas--(business wire)--tenet healthcare corporation (tenet) (nyse: thc) today announced its results for the quarter ended june 30, 2022 (q2'22). tenet's results for q2'22 versus the quarter ended june 30, 2021 (q2'21) are as follows: ($ in millions, except per share results) q2'22 q2'21 ytd q2'22 ytd q2'21 net income available to tenet common shareholders from continuing operations $38 $120 $177 $217 net income available to tenet common shareholders from continuing operations per diluted shar
THC Ratings Summary
THC Quant Ranking